ABcann Global Corporation Opens the Market

Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. ABcann Global Corporation commenced trading on TSX Venture Exchange on May 4, 2017. (CNW Group/TMX Group Limited)

TORONTO, Aug. 23, 2017 /CNW/ - Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). ABcann's flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. ABcann Global Corporation commenced trading on TSX Venture Exchange on May 4, 2017.

SOURCE TMX Group Limited